Project Grant 2208745
Award Date
6/1/22
Completion Date
11/30/22
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Asante Bio LLC (YFLQRVHCDKY1)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Norfolk, VA 23508, USA
Similar Awards
The National Science Foundation (NSF) awarded a $979,298 Cooperative Agreement under its Technology, Innovation, and Partnerships (CFDA 47.084) program to Asante Bio LLC, a small disadvantaged business, to develop a Multi-Axial Filament Winding Process (3DMF) for biomanufacturing high-performance orthobiologic implants for rotator cuff repair. This two-year project aims to optimize the manufacturing, surgical delivery, biomechanical performance, and biocompatibility of the 3DMF implants, which...
The National Science Foundation (NSF) awarded a Project Grant through its Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) to Georgia Tech Research Corporation in the amount of $249,689 for the project "3D Printed Tissue Implants for Facial Surgery." The project aims to develop a platform for 3D printing tissue implants for facial surgery, enabling the design and rapid manufacturing of implants for tissue reconstruction. The work will involve evaluating the impact...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $304,906 to Seabird Lifesciences LLC supports the development of an innovative bioprinting approach for creating vascular grafts that closely mimic the properties of natural blood vessels. The project aims to overcome limitations of current synthetic and biological grafts by utilizing a specialized bioprinting process that integrates a double-network hydrogel made from a Dacron...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Meteora3D, Incorporated will support the development of a rapid lift-based peel separation system for masked inverted stereolithography 3D printing. The goals of this 12-month project are to: 1) provide theoretical analysis of the peel process using fracture mechanics and control theory, 2) incorporate force feedback and peel detection into the peel control model, 3)...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) grant, awarded to Tissueform, Inc., a for-profit woman-owned small business in Boulder, Colorado, aims to develop a library of human-based bioinks for 3D bioprinting applications. The $274,822 award, with a performance period from September 2024 to August 2025, will focus on creating granulated bioinks for tissues such as cartilage, bone, skin, liver,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) project grant of $274,999 awarded to Materialize Bio, Inc. in Somerville, MA aims to develop a novel manufacturing approach for biopolymer-based implantable medical devices, specifically next-generation tympanostomy tubes. The project focuses on a groundbreaking method to 3D print molds, use centrifugation and polymerization to create complex biopolymer structures, and produce degradable, biocompatible,...
This NSF Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to President and Fellows of Harvard College (Harvard University) provides $550,000 in funding from August 1, 2024 to July 31, 2026 to develop a minimally-invasive, catheter-based additive manufacturing platform capable of creating customized medical implants directly inside the human body. The project aims to transform the field of medical implants by enabling on-demand fabrication of personalized 3D-printed...
Biosapien Inc. received a $256,000 Project Grant award from the National Science Foundation on May 1, 2021 to develop a novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner under the Small Business Innovation Research Phase I program. The SBIR Phase I grant supports the proof-of-concept stage of developing Biosapien's technology, with the work expected to be completed by June 30, 2022. The NSF Technology, Innovation, and...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $1,736,793 to The Pennsylvania State University (Penn State) from July 2024 through April 2028. The funding supports the development of a novel "3D Printing of Air" (3DAIRP) technology that can rapidly generate stable vascular networks...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $274,811 to Anova Biomedical, Inc. to develop 3D printed personalized vascular grafts using novel elastomeric resins. The key objectives are to: 1) develop and characterize the novel 3D printing resin for producing personalized, elastic, and bioresorbable vascular grafts; 2) demonstrate the ability to 3D print vascular prosthetics using patient CT...